ZA926903B - Crystalline etoposide 4'-phosphate diethanolate. - Google Patents

Crystalline etoposide 4'-phosphate diethanolate.

Info

Publication number
ZA926903B
ZA926903B ZA926903A ZA926903A ZA926903B ZA 926903 B ZA926903 B ZA 926903B ZA 926903 A ZA926903 A ZA 926903A ZA 926903 A ZA926903 A ZA 926903A ZA 926903 B ZA926903 B ZA 926903B
Authority
ZA
South Africa
Prior art keywords
crystalline etoposide
phosphate diethanolate
etoposide
phosphate
diethanolate
Prior art date
Application number
ZA926903A
Other languages
English (en)
Inventor
Denis Favreau
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA926903B publication Critical patent/ZA926903B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA926903A 1991-10-08 1992-09-10 Crystalline etoposide 4'-phosphate diethanolate. ZA926903B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/773,056 US5648474A (en) 1991-10-08 1991-10-08 Crystalline etoposide 4'-phosphate diethanolate

Publications (1)

Publication Number Publication Date
ZA926903B true ZA926903B (en) 1993-05-03

Family

ID=25097069

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA926903A ZA926903B (en) 1991-10-08 1992-09-10 Crystalline etoposide 4'-phosphate diethanolate.

Country Status (27)

Country Link
US (1) US5648474A (xx)
EP (1) EP0537555B1 (xx)
JP (1) JP3205816B2 (xx)
KR (1) KR100243981B1 (xx)
CN (1) CN1030610C (xx)
AT (1) ATE156832T1 (xx)
AU (1) AU650572B2 (xx)
CA (1) CA2079581C (xx)
CZ (1) CZ283735B6 (xx)
DE (1) DE69221573T2 (xx)
DK (1) DK0537555T3 (xx)
EG (1) EG20187A (xx)
ES (1) ES2109970T3 (xx)
FI (1) FI105034B (xx)
GR (1) GR3025176T3 (xx)
HU (2) HU213606B (xx)
IL (1) IL103262A (xx)
MX (1) MX9205777A (xx)
MY (1) MY108969A (xx)
NO (1) NO178342C (xx)
NZ (1) NZ244521A (xx)
PH (1) PH31666A (xx)
PL (1) PL168332B1 (xx)
RU (1) RU2042686C1 (xx)
SK (1) SK278935B6 (xx)
TW (1) TW239863B (xx)
ZA (1) ZA926903B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914222A (en) * 1983-08-29 1990-04-03 Merck & Co., Inc. Crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
US4670578A (en) * 1983-08-29 1987-06-02 Merck & Co., Inc. Process for crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US4904768A (en) * 1987-08-04 1990-02-27 Bristol-Myers Company Epipodophyllotoxin glucoside 4'-phosphate derivatives
EP0369369B1 (en) * 1988-11-16 1994-01-26 Nippon Kayaku Kabushiki Kaisha Dihydrate crystals of etoposide-2-dimethylamino compound hydrochloride and a process for production thereof
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides

Also Published As

Publication number Publication date
MX9205777A (es) 1993-04-01
KR100243981B1 (ko) 2000-02-01
NZ244521A (en) 1994-02-25
CZ283735B6 (cs) 1998-06-17
CN1071432A (zh) 1993-04-28
NO923754D0 (no) 1992-09-28
CN1030610C (zh) 1996-01-03
ATE156832T1 (de) 1997-08-15
IL103262A0 (en) 1993-02-21
FI924359A0 (fi) 1992-09-29
DE69221573D1 (de) 1997-09-18
AU650572B2 (en) 1994-06-23
HUT62309A (en) 1993-04-28
MY108969A (en) 1996-11-30
EP0537555B1 (en) 1997-08-13
SK298692A3 (en) 1998-04-08
IL103262A (en) 1997-06-10
FI105034B (fi) 2000-05-31
DK0537555T3 (da) 1998-01-26
NO923754L (no) 1993-04-13
PH31666A (en) 1999-01-12
PL168332B1 (pl) 1996-02-29
HU213606B (en) 1997-08-28
GR3025176T3 (en) 1998-02-27
DE69221573T2 (de) 1998-02-26
NO178342B (no) 1995-11-27
PL296078A1 (en) 1993-04-19
US5648474A (en) 1997-07-15
RU2042686C1 (ru) 1995-08-27
CA2079581A1 (en) 1993-04-09
EG20187A (en) 1997-09-30
CA2079581C (en) 2002-11-12
NO178342C (no) 1996-03-06
EP0537555A1 (en) 1993-04-21
CZ298692A3 (en) 1993-04-14
HU9203119D0 (en) 1992-12-28
KR930007968A (ko) 1993-05-20
ES2109970T3 (es) 1998-02-01
JP3205816B2 (ja) 2001-09-04
TW239863B (xx) 1995-02-01
FI924359A (fi) 1993-04-09
AU2530192A (en) 1993-04-22
SK278935B6 (sk) 1998-04-08
JPH05194575A (ja) 1993-08-03
HU211672A9 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
GB2237945B (en) Process,supply,temperature compensating CMOS output buffer
HU9204076D0 (en) Method for producing 4,13-dioxa-bicyclo(8.2.1)-tridecenone derivatives
KR960004869B1 (en) Process for preparing 1,1,12-tetrafluoro-ethane
ZA924594B (en) Process for making 1,3,5,7-tetranitro-1,3,5,7-tetraazacyclooctane
HUT55368A (en) Herbicidal compositions comprising substituted 4-amino-5-(alkylthio)-1,2,4-triazol-3-ones and process for producing the compounds
AU1077992A (en) Process for preparing 1,3-dioxols
GR3002962T3 (en) C.12 modified erythromycin a derivatives
ZA938576B (en) Process for preparing 1,3-difluorobenzene
TW239863B (xx)
EP0480465A3 (en) Process for preparing 5-aroyl-2,3-dihydro-1h-pyrrolizine-1,1,-dicarboxylates
AR243607A1 (es) Un procedimiento para la produccion de des(64,65)proinsulina humana.
IL104477A0 (en) Process for preparing 4,6-dialkoxy-pyrimidines
CS389491A3 (en) Process for preparing 4-substituted 2,6-dialkylanilines
HU206496B (en) Process for producing 2,3-dichloro-6-nitro-benzonitril
HU911706D0 (en) Process for producing 2,3-dichlorine-6-amino-benzol derivatives
CS659990A3 (en) Process for preparing crystalline 3,4-dimethyl-phenyl-n-d-ribitylamine
HU208016B (en) Process for producing 15,20-anhydrovinblastin-borane-complex
YU35190A (en) Process for obtaining 2,4-bis(1,2,3,4-tetrahydronaphtyl-1- and 1,2,3,4-tetrahydronaphtyl-2-amino) -6-chlorine-s-triazine
CS688090A3 (en) Process for preparing 1,2,3,-trichloro-4-nitrobenzene
CS259690A3 (en) Process for preparing 1,1,3-trimethyl-3-phenylindane
CS365690A3 (en) Process for preparing 2-amino-4-chloro-6-methyl-1,3,5-triazine